CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 122 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2023. The put-call ratio across all filers is 1.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,147,603 | -34.1% | 52,570 | -4.0% | 0.00% | -20.0% |
| Q2 2023 | $1,740,407 | +23.7% | 54,747 | -5.1% | 0.01% | +25.0% |
| Q1 2023 | $1,406,620 | -28.6% | 57,672 | -7.7% | 0.00% | -33.3% |
| Q4 2022 | $1,970,209 | +17.1% | 62,467 | +4.9% | 0.01% | +20.0% |
| Q3 2022 | $1,683,000 | +23.5% | 59,551 | +15.5% | 0.01% | +25.0% |
| Q2 2022 | $1,363,000 | -27.5% | 51,558 | -4.0% | 0.00% | 0.0% |
| Q1 2022 | $1,880,000 | +8.0% | 53,700 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $1,741,000 | +29.4% | 53,700 | +17.8% | 0.00% | 0.0% |
| Q3 2021 | $1,345,000 | +15.2% | 45,600 | 0.0% | 0.00% | +50.0% |
| Q2 2021 | $1,168,000 | – | 45,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |